Protocol for Designing Small-Molecule-Regulated Destabilizing Domains for In Vitro Use

The use of destabilizing domains (DDs) to conditionally control the abundance of a protein of interest (POI) through a small-molecule stabilizer has gained increasing traction both in vitro and in vivo. Yet there are specific considerations for the development and accurate control of user-defined PO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramadurgum, Prerana, Hulleman, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521665/
https://www.ncbi.nlm.nih.gov/pubmed/32995752
http://dx.doi.org/10.1016/j.xpro.2020.100069
Descripción
Sumario:The use of destabilizing domains (DDs) to conditionally control the abundance of a protein of interest (POI) through a small-molecule stabilizer has gained increasing traction both in vitro and in vivo. Yet there are specific considerations for the development and accurate control of user-defined POIs via DDs, as well as the identification of novel (and potentially synergistic) small-molecule stabilizers. Here, we describe a platform for achieving these goals. For complete details on the use and execution of this protocol, please refer to Ramadurgum et al. (2020).

Ejemplares similares